Theravance Biopharma Inc • TBPH

Capital at risk.

About Theravance Biopharma Inc
Ticker
info
TBPH
Trading on
info
NASDAQ
ISIN
info
KYG8807B1068
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Rick E. Winningham M.B.A.
Headquarters
info
901 Gateway Boulevard, South San Francisco, CA, United States, 94080
Employees
info
97
Website
info
theravance.com
Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD). Its late-stage investigational once-daily norepinephrine reuptake inhibitor, Ampreloxetine is in the development for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA). It has a strategic collaboration agreement with Viatris Inc. for the development and commercialization of revefenacin, including YUPELRI. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.
Metrics
BasicAdvanced
Market cap
info
$910M
P/E ratio
info
31.49
EPS
info
$0.57
Dividend Yield
info
0.00%
Beta
info
0.18
Forward P/E ratio
info
9.43
EBIDTA
info
$-31.2M
Ex dividend date
info
-
Price & volume
Market cap
info
$910M
Average daily volume
info
0.4M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
31.49
Forward P/E
info
9.43
PEG ratio
info
-0.05
Trailing P/E
info
31.49
Price to sales
info
11.32
Price to book
info
3.87
Earnings
EPS
info
$0.57
EPS estimate (current quarter)
info
-$0.05
EPS estimate (next quarter)
info
$0.15
EBITDA
info
$-31.2M
Revenues (TTM)
info
$80.3M
Revenues per share (TTM)
info
$1.61
Technicals
Beta
info
0.18
52-week High
info
$18.96
52-week Low
info
$7.90
50-day moving average
info
$14.40
200-day moving average
info
$11.34
Short ratio
info
17.2
Short %
info
16.10%
Management effectiveness
ROE (TTM)
info
14.03%
ROA (TTM)
info
-5.32%
Profit margin
info
36.53%
Gross profit margin
info
$40.8M
Operating margin
info
-32.29%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
18.50%
Share stats
Outstanding Shares
info
50.7M
Float
info
22M
Insiders %
info
4.37%
Institutions %
info
94.27%
Analyst Insights & forecasts
info

50% Buy

50% Hold

0% Sell

Based on information from 4 analysts.

Average price target

info
$21.50
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.05
-$0.08
39.86%
Q4 • 24Beat
-$0.17
-$0.09
-92.67%
Q1 • 25Missed
-$0.08
$0.67
-112.51%
Q2 • 25Missed
$0.04
-$0.13
132.58%
Q3 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$26.2M
$54.8M
209.33%
Q2 • 25
$20M
$3.6M
18.08%
Q3 • 25
-23.69%
-93.41%
-91.36%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$426M
$201M
47.22%
Q2 • 25
$415M
$183M
43.99%
Q3 • 25
-2.48%
-9.15%
-6.84%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$208M
$-36.3M
$-0.5M
$208M
Q2 • 25
$-6.5M
$-100M
$-0.4M
$-6.5M
Q3 • 25
-103.13%
176.48%
-20.48%
-103.13%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Theravance Biopharma Inc share?
Collapse

Theravance Biopharma Inc shares are currently traded for undefined per share.

How many shares does Theravance Biopharma Inc have?
Collapse

Theravance Biopharma Inc currently has 50.7M shares.

Does Theravance Biopharma Inc pay dividends?
Collapse

No, Theravance Biopharma Inc doesn't pay dividends.

What is Theravance Biopharma Inc 52 week high?
Collapse

Theravance Biopharma Inc 52 week high is $18.96.

What is Theravance Biopharma Inc 52 week low?
Collapse

Theravance Biopharma Inc 52 week low is $7.90.

What is the 200-day moving average of Theravance Biopharma Inc?
Collapse

Theravance Biopharma Inc 200-day moving average is $11.34.

Who is Theravance Biopharma Inc CEO?
Collapse

The CEO of Theravance Biopharma Inc is Rick E. Winningham M.B.A..

How many employees Theravance Biopharma Inc has?
Collapse

Theravance Biopharma Inc has 97 employees.

What is the market cap of Theravance Biopharma Inc?
Collapse

The market cap of Theravance Biopharma Inc is $910M.

What is the P/E of Theravance Biopharma Inc?
Collapse

The current P/E of Theravance Biopharma Inc is 31.49.

What is the EPS of Theravance Biopharma Inc?
Collapse

The EPS of Theravance Biopharma Inc is $0.57.

What is the PEG Ratio of Theravance Biopharma Inc?
Collapse

The PEG Ratio of Theravance Biopharma Inc is -0.05.

What do analysts say about Theravance Biopharma Inc?
Collapse

According to the analysts Theravance Biopharma Inc is considered a buy.